Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

NCT00002869 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

800

Enrollment

OTHER_GOV

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: recombinant interferon alfa
DRUG: cytarabine
DRUG: hydroxyurea

Sponsor

Medical Research Council